Green Chip Stocks Appearances

How to Profit From the End of Aging

Why This Anti-Aging Stock Could Double in Three Weeks

By Jeff Siegel on August 6, 2020
Right now, there’s a company that’s developed a pharmaceutical-based treatment that could allow you to not only live a longer life, but do so in a way that would allow you to never have to worry about getting any age-related chronic diseases. And it's public.

The Tesla of Biotech Stocks

Only Communists Drive Teslas

By Jeff Siegel on July 30, 2020
Change happens. And while change can be hard for some folks to accept, it shouldn’t be hard to profit from. Energy and Capital editor Jeff Siegel discusses some upcoming change in the biotech sector and how investors can profit...

How to Make Money While in Quarantine

Three Stocks to Own as COVID Makes a Comeback

By Jeff Siegel on July 23, 2020
Today, Energy and Capital editor Jeff Siegel is simply going to share with you three reports that focus on a handful of companies that are already proving to be COVID-resistant...

Investing in Anti-Aging Biotech Stocks

By Jeff Siegel on July 16, 2020
Some have called it the most undervalued stock in the biotech space. Energy and Capital editor Jeff Siegel profiles a stock that has developed an anti-aging pill that could change humanity as we know it...

Investing in the Cure for Chronic Disease

By Jeff Siegel on July 9, 2020
Energy and Capital editor Jeff Siegel is very bullish right now on a small biotech firm that’s currently conducting clinical trials on a new drug that looks like it could not only completely cure chronic diseases, but even reverse them...

Investing in Anti-Aging Stocks

By Jeff Siegel on July 2, 2020
Doctors from biotech firm Verve Therapeutics have developed a new gene-editing serum that switches off the genes that regulate both LDL cholesterol and triglycerides.  Energy and Capital editor Jeff Siegel explains how investors can take advantage...